EGFR and lung adenocarcinoma: The mechanism of higher incidence of EGFR mutation in well- to moderately differentiated lung adenocarcinoma is likely a reflection of lower mutation burden associated with more indolent clinical course driven by the classic EGFR-driver mutation as a characteristic of molecular evolution of cancer initiated by a single driver mutation [28,29].